Allergan Aesthetics
Michelle Hinds currently serves as the National Director of AHCP Thought Leader Development at Allergan Aesthetics, an AbbVie Company, beginning in September 2023. With extensive experience at Allergan Aesthetics since 2018, Michelle has held roles including Director of Thought Leader Engagement and Development, where responsibilities included crafting KOL and healthcare practitioner engagement programs. Previous positions at Allergan and Valeant Pharmaceuticals involved building customer advocacy, leading educational initiatives, and managing sales strategies across various regions. Michelle's career began with leadership and sales roles in staffing and human resources. Academic credentials include a Bachelor of Arts in Psychology from California State University, Chico.
This person is not in any teams
This person is not in any offices
Allergan Aesthetics
7 followers
At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. At Allergan Aesthetics™ we believe in the remarkable impact confidence can have on the lives, businesses, and careers of those we serve through our history of a company built on patient-care, education and support of our customers, and our commitment to putting the patients we serve first. That’s why we dedicate ourselves, every day, united by a single purpose: empowering confidence. For our customers, their patients and one another. Review our LinkedIn community guidelines at https://news.abbvie.com/social-media/